Scientific evidence classification · Phase 6A preserved + Phase 6B additions
PWWP Compounds
& Bioactivity
Explore experimentally studied preparations separately from deposited research ligands, buffers, ions and unresolved chemical evidence. Every role is source- and target-context specific.
Combined Phase 6A + Phase 6B denominators. These groups overlap; the 109 structurally source-tagged research ligands are unchanged. Deposited components and reagents are not automatically biochemical binders.
Phase 6B · source-reviewed additions (separate from the Phase 6A snapshot)
0 matching new observations · 0 preparations
Keep source-level IC50, Kd, and whole-protein DC50 separate; these records were not included in the original 80.
| Preparation | Target scope | Original assay | Primary source |
|---|---|---|---|
| No Phase 6B additions match the selected observation-level filters. This does not erase existing Phase 6A observations. | |||
Evidence classification · exact source records
11 matching profiles
13 matching assay / association observations. Counts here are profiles, not unique assay events or deposited ligand instances; views overlap.
BI-9466
No source-curated measured assay in this context. Structural evidence is shown separately.
Measurements remain attached to the reported preparation.
compound 11 (Collie 2025)
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 12 (Collie 2025)
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 13 (Collie 2025)
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 5 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 6 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
compound 7 (Collie 2025)
MS9715
Measurements remain attached to the reported preparation.
MS9715N
Unresolved preparation · individual modeled components do not inherit its potency.